For laboratory research use only.Not for human or veterinary use. Not for diagnostic or therapeutic use. Supplied only to verified research institutions in Canada.
QuadBioResearch reagents · Canada

Catalogue / Tissue & wound-model research

QB-1003Tissue & wound-model researchLyophilized · ≥ 98 % HPLC

GHK-Cu

Glycyl-L-histidyl-L-lysine copper(II); copper tripeptide-1

Identity

Sequence
GHK · Cu(II)
Three-letter
Gly-His-Lys · Cu²⁺ (1:1)
Length
3 residues
Modifications
Copper(II) complex; supplied as blue lyophilized powder
Formula
C14H24N6O4 · Cu
Average mass
340.4 (peptide); ≈403.9 (complex) Da
CAS
89030-95-5 (complex); 49557-75-7 (GHK)

Specifications (per released lot)

Purity
≥ 98 % by RP-HPLC, 220 nm
Identity
ESI-MS; observed mass within 0.1 % of calculated
Form
White to off-white lyophilized powder (blue for the copper complex)
Counter-ion
Trifluoroacetate; acetate on request
Net peptide content
Reported per lot (typically 70–90 % of gross mass; the balance is counter-ion and water)
Vial sizes
5 mg · 10 mg · 25 mg net peptide; bulk on quotation
Storage
−20 °C, desiccated, protected from light. Ships at ambient temperature.
Documents
Lot certificate of analysis (COA library); safety data sheet in WHMIS 2015 format, enclosed with every shipment

Research context

Tripeptide–copper(II) complex first isolated from human plasma. Used in fibroblast, collagen-synthesis and wound-model studies and in cosmetic-science formulation research.

Literature context is provided to help laboratories identify the reagent. It is not a claim about effects in people and does not describe any use outside in-vitro or approved animal research.